100 million doses of Sinopharm’s COVID-19 vaccines supplied worldwide

Spread the love

A Sinopharm affiliate said on Friday that the two COVID-19 vaccines developed by China National Pharmaceutical Group (Sinopharm) subsidiaries have hit a combined 100 million doses of supply worldwide. 

According to China National Biotec Group Company (CNBG), over 80 million doses of the two vaccines were administered.

An annual capacity of 1 billion jabs could be reached in 2021 and Sinopharm aims to expand capacity to 3 billion doses per year, without specifying the timeframe for the target.

On Monday, another Chinese vaccine maker Sinovac Biotech said it had supplied 160 million doses of its COVID-19 vaccine to 18 countries and regions, including China, with over 70 million shots injected.

Including the vaccine from CanSino Biologics Inc, a total of 4 vaccines have been approved in China for general public use. A fifth vaccine developed by the Institute of Microbiology Chinese Academy of Sciences has gained clearance for limited emergency use.

House committees to hold hearings during break

Spread the love

Spread the loveMANILA – The House of Representatives has authorized for its committees to conduct hearings during the five-week congressional break, extending until late April.